• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人源微小RNA-34a-5p通过靶向沉默信息调节因子1(SIRT1)的3'-非翻译区并抑制其表达来逆转胃癌细胞的多药耐药性。

Hsa-miR-34a-5p reverses multidrug resistance in gastric cancer cells by targeting the 3'-UTR of SIRT1 and inhibiting its expression.

作者信息

Deng X J, Zheng H L, Ke X Q, Deng M, Ma Z Z, Zhu Y, Cui Y Y

机构信息

Department of Gastroenterology, The First Affiliated Hospital of Bengbu Medical College, China; Department of Gastroenterology, The First Affiliated Hospital of Jinan University, China.

Department of Gastroenterology, The First Affiliated Hospital of Bengbu Medical College, China.

出版信息

Cell Signal. 2021 Aug;84:110016. doi: 10.1016/j.cellsig.2021.110016. Epub 2021 Apr 22.

DOI:10.1016/j.cellsig.2021.110016
PMID:33894312
Abstract

Multidrug resistance (MDR) is a major obstacle to chemotherapy, which leads to ineffective chemotherapy, an important treatment strategy for gastric cancer (GC). The abnormality of microRNAs (miRNAs) is critical to the occurrence and progression of MDR in various tumors. In this study, hsa-miR-34a-5p was found to be decreased in multidrug resistant GC cells SGC-7901/5-Fluorouracil (SGC-7901/5-Fu) compared to the parental SGC-7901 cells. Overexpression of hsa-miR-34a-5p in SGC-7901/5-Fu cells promoted apoptosis and decreased migration and invasiveness after chemotherapy. In addition, overexpression of hsa-miR-34a-5p suppressed the growth of drug-resistant tumor in vivo. The mechanism of the effects of hsa-miR-34a-5p could include the regulation of the expression of Sirtuin 1 (SIRT1), P-glycoprotein (P-gp) or Multidrug resistance-related protein 1 (MRP1) through direct binding to the 3'-untranslated region (UTR) of SIRT1. Functional gain-and-loss experiments indicated that hsa-miR-34a-5p enhances the chemotherapy sensitivity of MDR GC cells by inhibiting SIRT1, P-gp and MRP1. In conclusion, hsa-miR-34a-5p can reverse the MDR of GC cells by inhibiting the expression of SIRT1, P-gp or MRP1.

摘要

多药耐药(MDR)是化疗的主要障碍,它会导致化疗无效,而化疗是胃癌(GC)的一种重要治疗策略。微小RNA(miRNA)的异常对于各种肿瘤中MDR的发生和发展至关重要。在本研究中,发现与亲代SGC-7901细胞相比,多药耐药的GC细胞SGC-7901/5-氟尿嘧啶(SGC-7901/5-Fu)中hsa-miR-34a-5p表达降低。在SGC-7901/5-Fu细胞中过表达hsa-miR-34a-5p可促进细胞凋亡,并在化疗后降低细胞迁移和侵袭能力。此外,hsa-miR-34a-5p过表达在体内抑制耐药肿瘤的生长。hsa-miR-34a-5p发挥作用的机制可能包括通过直接结合沉默调节蛋白1(SIRT1)的3'-非翻译区(UTR)来调控SIRT1、P-糖蛋白(P-gp)或多药耐药相关蛋白1(MRP1)的表达。功能获得和缺失实验表明,hsa-miR-34a-5p通过抑制SIRT1、P-gp和MRP1增强MDR GC细胞的化疗敏感性。总之,hsa-miR-34a-5p可通过抑制SIRT1、P-gp或MRP1的表达来逆转GC细胞的MDR。

相似文献

1
Hsa-miR-34a-5p reverses multidrug resistance in gastric cancer cells by targeting the 3'-UTR of SIRT1 and inhibiting its expression.人源微小RNA-34a-5p通过靶向沉默信息调节因子1(SIRT1)的3'-非翻译区并抑制其表达来逆转胃癌细胞的多药耐药性。
Cell Signal. 2021 Aug;84:110016. doi: 10.1016/j.cellsig.2021.110016. Epub 2021 Apr 22.
2
The miR27b-CCNG1-P53-miR-508-5p axis regulates multidrug resistance of gastric cancer.miR27b-CCNG1-P53-miR-508-5p轴调控胃癌的多药耐药性。
Oncotarget. 2016 Jan 5;7(1):538-49. doi: 10.18632/oncotarget.6374.
3
miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1.miR-508-5p 通过靶向 ABCB1 和 ZNRD1 调节胃癌的多药耐药性。
Oncogene. 2014 Jun 19;33(25):3267-76. doi: 10.1038/onc.2013.297. Epub 2013 Jul 29.
4
High glucose up-regulates microRNA-34a-5p to aggravate fibrosis by targeting SIRT1 in HK-2 cells.高糖通过靶向HK-2细胞中的SIRT1上调微小RNA-34a-5p以加重纤维化。
Biochem Biophys Res Commun. 2018 Mar 25;498(1):38-44. doi: 10.1016/j.bbrc.2017.12.048. Epub 2018 Jan 31.
5
C1q/tumor necrosis factor-related protein-6 attenuates TNF-α-induced apoptosis in salivary acinar cells via AMPK/SIRT1-modulated miR-34a-5p expression.C1q/肿瘤坏死因子相关蛋白-6 通过 AMPK/SIRT1 调控的 miR-34a-5p 表达减轻唾液腺细胞中 TNF-α诱导的细胞凋亡。
J Cell Physiol. 2021 Aug;236(8):5785-5800. doi: 10.1002/jcp.30262. Epub 2021 Jan 5.
6
Altered Expression of CD44, SIRT1, CXCR4, miR-21, miR-34a, and miR-451 Genes in MKN-45 Cell Line After Docetaxel Treatment.多西他赛处理后 MKN-45 细胞系中 CD44、SIRT1、CXCR4、miR-21、miR-34a 和 miR-451 基因的表达变化。
J Gastrointest Cancer. 2020 Jun;51(2):520-526. doi: 10.1007/s12029-019-00274-1.
7
Inhibition of sirtuin 1 deacetylase by miR-211-5p provides a mechanism for the induction of cell death in breast cancer cells.miR-211-5p 通过抑制组蛋白去乙酰化酶 1 提供了诱导乳腺癌细胞死亡的机制。
Gene. 2019 Aug 30;711:143939. doi: 10.1016/j.gene.2019.06.029. Epub 2019 Jun 18.
8
Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway.外泌体 microRNA-107 通过 HMGA2/mTOR/P-gp 通路逆转胃癌细胞的化疗耐药性。
BMC Cancer. 2021 Dec 2;21(1):1290. doi: 10.1186/s12885-021-09020-y.
9
MiR-34a-5p promotes hepatic gluconeogenesis by suppressing SIRT1 expression.miR-34a-5p 通过抑制 SIRT1 表达促进肝糖异生。
Exp Cell Res. 2022 Nov 1;420(1):113336. doi: 10.1016/j.yexcr.2022.113336. Epub 2022 Sep 1.
10
miR-34a-5p up-regulates the IL-1β/COX2/PGE2 inflammation pathway and induces the release of CGRP via inhibition of SIRT1 in rat trigeminal ganglion neurons.在大鼠三叉神经节神经元中,miR-34a-5p通过抑制SIRT1上调IL-1β/COX2/PGE2炎症通路并诱导降钙素基因相关肽(CGRP)的释放。
FEBS Open Bio. 2021 Jan;11(1):300-311. doi: 10.1002/2211-5463.13027. Epub 2020 Dec 16.

引用本文的文献

1
Clinical significance and prognostic value of SIRT1 genetic variants in sepsis: a multicenter hospital-based case-control study.脓毒症中SIRT1基因变异的临床意义及预后价值:一项基于多中心医院的病例对照研究。
Clin Epigenetics. 2025 Jul 30;17(1):135. doi: 10.1186/s13148-025-01944-7.
2
The role of SIRT1 in the development of gastrointestinal tumors.沉默信息调节因子1在胃肠道肿瘤发生发展中的作用。
Front Cell Dev Biol. 2025 Jun 11;13:1606530. doi: 10.3389/fcell.2025.1606530. eCollection 2025.
3
Deciphering the role of nicotinamide metabolism and melanin-related genes in acute myocardial infarction: a machine learning approach integrating bioinformatics analysis.
解读烟酰胺代谢和黑色素相关基因在急性心肌梗死中的作用:一种整合生物信息学分析的机器学习方法
Korean J Physiol Pharmacol. 2025 Jul 1;29(4):521-532. doi: 10.4196/kjpp.24.431. Epub 2025 May 26.
4
Integration of MicroRNAs with nanomedicine: tumor targeting and therapeutic approaches.微小RNA与纳米医学的整合:肿瘤靶向与治疗方法
Front Cell Dev Biol. 2025 Apr 7;13:1569101. doi: 10.3389/fcell.2025.1569101. eCollection 2025.
5
Comprehensive analysis of mRNA expression of Piezo1 and Piezo2 in tumor samples and their prognostic implications in gastric cancer.Piezo1和Piezo2在肿瘤样本中的mRNA表达综合分析及其对胃癌的预后意义。
Discov Oncol. 2025 Apr 21;16(1):582. doi: 10.1007/s12672-025-02309-5.
6
MicroRNA-34a negatively regulates Netrin1 and mediates MEK/ERK pathway to regulate chemosensitivity of gastric cancer cells.微小RNA-34a负向调节神经纤毛蛋白1,并介导MEK/ERK信号通路以调节胃癌细胞的化学敏感性。
Discov Oncol. 2024 Oct 15;15(1):563. doi: 10.1007/s12672-024-01451-w.
7
MicroRNA-34 and gastrointestinal cancers: a player with big functions.微小RNA-34与胃肠道癌症:一个功能强大的参与者。
Cancer Cell Int. 2024 May 9;24(1):163. doi: 10.1186/s12935-024-03338-w.
8
Sirt6-Mediated Cell Death Associated with Sirt1 Suppression in Gastric Cancer.Sirt6介导的细胞死亡与胃癌中Sirt1的抑制相关
Cancers (Basel). 2024 Jan 16;16(2):387. doi: 10.3390/cancers16020387.
9
Restoring microRNA-34a overcomes acquired drug resistance and disease progression in human breast cancer cell lines via suppressing the ABCC1 gene.通过抑制 ABCC1 基因,恢复 microRNA-34a 可克服人乳腺癌细胞系中的获得性耐药和疾病进展。
Breast Cancer Res Treat. 2024 Feb;204(1):133-149. doi: 10.1007/s10549-023-07170-0. Epub 2023 Dec 7.
10
MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential.癌症中的MicroRNA-34家族:作用、机制及治疗潜力
Cancers (Basel). 2023 Sep 26;15(19):4723. doi: 10.3390/cancers15194723.